Imbed Biosciences secures financing for MicroLyte Ag Antimicrobial Matrix
Imbed Biosciences, a Wisconsin-based medical device company, development of advanced therapies for soft tissue repair, has raised $2 million in a Series A financing round. The proceeds from the financing round are expected to help the medical device company commercialize its FDA-approved MicroLyte Ag Antimicrobial Matrix, which is indicated for the management of burns, chronic […]